DJIA52475.10 97.53
S&P 5007743.98 21.38
NASDAQ26549.85 72.04
Russell 20002830.51 11.64
German DAX25697.45 90.80
FTSE 10010694.50 7.96
CAC 407886.96 -0.18
EuroStoxx 506166.55 1.90
Nikkei 22563954.19 685.82
Hang Seng23094.83 53.51
Shanghai Comp3681.47 33.17
KOSPI6012.44 374.10
Bloomberg Comm IDX142.38 0.47
WTI Crude-fut114.10 0.15
Brent Crude-fut102.82 2.97
Natural Gas3.47 -0.03
Gasoline-fut3.11 0.05
Gold-fut4081.20 4.20
Silver-fut54.04 -0.50
Platinum-fut1544.70 -1.90
Palladium-fut1011.00 -25.00
Copper-fut6.67 0.01
Aluminum-spot3195.00 0.00
Coffee-fut286.35 -7.90
Soybeans-fut1237.00 -6.25
Wheat-fut599.50 -11.50
Bitcoin81114.04 210.41
Ethereum USD2360.28 8.99
Litecoin59.13 2.26
Dogecoin0.08 0.00
EUR/USD1.1134 -0.0052
USD/JPY157.73 0.07
GBP/USD1.3313 -0.0046
USD/CHF0.8286 0.0010
USD IDX102.13 -0.22
US 10-Yr TR5.003 0.01
GER 10-Yr TR3.3621 -0.02
UK 10-Yr TR5.3511 0.0152
JAP 10-Yr TR2.826 0.001
Fed Funds4 0
SOFR3.95 0.02
High-rise commercial buildings

Sub Markets

Topics

Alternative Assets  + Hedge Funds  + Private Equity  | 
Rising PE Firm Catalio Capital Management to Buy Hedge Fund Healthcor

Rising PE Firm Catalio Capital Management to Buy Hedge Fund Healthcor

Up and coming Catalio Capital Management is acquiring HealthCor Management, a healthcare-focused hedge fund founded by veteran investors Art Chen and Joe Healey.  

According to STAT News the deal is expected to close in 2023 and is mostly a stock transaction. 

Launched in 2005, HealthCor is a value-based investor dedicated to identifying global healthcare and life science equity securities that are mispriced. 

Healey and Cohen have an extensive career of investing in the sector and have co-invested for over 20 years as a team.  

Catalio Capital is a multi-strategy life sciences investment firm that manages more than $1bn in assets across its private equity, private credit and public equities strategies. 

The news follows Catalio’s close of its debut special situations fund in November – Catalio Credit Opportunities Fund I, an $85 million fund that will invest in small and mid-sized life sciences companies at various stages of growth. 

The fund is the second investment vehicle that Catalio has raised in 2022, following the close of Catalio Nexus Fund III, the firm’s third flagship private equity fund, earlier this year.

Connect

Inside The Story

Catalio Capital Management

About Joe Palmisano

Joe Palmisano is editorial director of Connect Money, where he oversees daily coverage of alternative assets, direct investments, financial advisory and the economy. He brings three decades of experience as a financial journalist, analyst and portfolio manager. Before joining Connect Money, Palmisano wrote for The Wall Street Journal, covering foreign exchange, global fixed-income and equity markets. He later served as a senior research analyst and portfolio manager, producing market analysis and managing foreign exchange and U.S. equity portfolios for FX Concepts. His work has also appeared in SFO Magazine and CMT Association publications. Palmisano earned a bachelor’s degree in finance from The American University and holds the Chartered Market Technician (CMT) designation and is a member of the CFA Institute.